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ABSTRACT: We report a simple and sensitive surface-enhanced
Raman scattering (SERS) platform for the detection of heparin, based
on antiaggregation of 4-mercaptopyridine (4-MPY) functionalized silver
nanoparticles (Ag NPs). Here, protamine was employed as a medium for
inducing the aggregation of negatively charged 4-MPY functionalized Ag
NPs through surface electrostatic interaction, which resulted in
signiﬁcantly enhanced Raman signal of the Raman reporter. However,
in the presence of heparin, the interaction between heparin and
protamine decreased the concentration of free protamine, which
dissipated the aggregated 4-MPY functionalized Ag NPs and thus
decreased Raman enhancement eﬀect. The degree of aggregation and
Raman enhancement eﬀect was proportional to the concentration of
added heparin. Under optimized assay conditions, good linear
relationship was obtained over the range of 0.5−150 ng/mL (R2 = 0.998) with a minimum detectable concentration of 0.5
ng/mL in standard aqueous solution. Furthermore, the developed method was also successfully applied for detecting heparin in
fetal bovine serum samples with a linear range of 1−400 ng/mL.
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■ INTRODUCTION
Heparin is a highly negatively charged glycosaminoglycan,
which has a molecular weight range from 5000 to 40 000 with
average charge up to ∼70.1 It plays a vital role in the regulation
of various normal physiological and pathological processes such
as venous thromboembolism, lipid transport and metabolism,
cell growth and diﬀerentiation, and blood coagulation.2−5 On
the contrary, the overdose of heparin often induces
hemorrhage, thrombocytopenia, or other bleeding complica-
tion.6,7 So, the United States, European Union, and China have
upgraded inspection standards of heparin after the “heparin
incident” in 2008.8 The therapeutic dosing level of heparin is
2−8 U/mL (17−67 μM) during cardiovascular surgery and
0.2−1.2 U/mL (1.7−10 μM) for postoperative and long-term
care.9 However, quantitative measurement of heparin seems to
be diﬃcult due to its natural polydispersity, chemical
heterogeneity, and lack of ﬂuorescent properties or signiﬁcant
absorbance.10 Therefore, the development of sensitive,
selective, and simple sensing strategy for the detection of
heparin has attracted considerable research eﬀorts in recent
years.
To date, various methods had been used for detection of
heparin, such as, ﬂuorescent,11,12 electrochemistry,13 light
scattering,14 spectrophotometry,15 and colorimetry.16,17 Typi-
cally, Li’s group developed a simple and sensitive method for
visual detection of heparin using positively charged gold
nanoparticles as colorimetric probes with a detection limit of
0.03 μg/mL.17 Wang’s group provided the ratiometric
ﬂuorescence sensor based on a pyrene derivative and
quantiﬁcation detection of heparin in aqueous solution and
serum. The detection limit of the sensor is 0.157 μM, and its
linear range is 5−30 μM.18 Li’s group reported the electro-
chemical sensor for heparin based on a poly(thionine) modiﬁed
glassy carbon electrode.19 Although these existing methods can
measure heparin to microgram per liter concentrations, there is
still urgently necessary to explore simpler and more sensitive
methods for ﬁeld assays.
Surface-enhanced Raman scattering (SERS) technique,
which extraordinary sensitivity for applications in numerous
chemical and biological systems, has attracted great attention
and become a powerful spectroscopy technique.20,21 Its two
well-known primary theoretical mechanism models are long-
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range electromagnetic (EM) enhancement and short-range
chemical enhancement (CE). EM enhancement emphasizes the
eﬀect of the nanosubstrate providing the long-range electro-
magnetic ﬁelds, which determined by the nanosubstrate’s
inherent properties (material type, shape, and size). And CE is
achieved by changing the scattering cross section of the analytes
attached on a metal surface, thus depends on the chemical
features of the analytes themselves.21,22 It is acknowledged that
EM enhancements always considered as the major contribution
to the SERS phenomenon.23,24 Since its discovery in the late
1970s, SERS has been applied to many analyses. Speciﬁcally, it
possesses great potential in nucleic acid and metal ions
detection systems, immunoassay, cell imaging, and cancer
therapeutics, which are mainly due to its nearly 104−106 fold
enhancement in comparison with normal Raman spectra, lack
of photobleaching and self-quenching, as well as the use of a
single laser wavelength for multiple species.25,26 Recently,
various nanoparticles-based SERS applications have been
reported, based on the fact that SERS signal of Raman reporter
tagged on the nanoparticles can be signiﬁcantly enhanced by
the interparticle plasmonic coupling induced by the aggregation
of nanoparticles. For example, Zamarion’s group reported
ultrasensitive SERS nanoprobes for hazardous metal ions based
on trimercaptotriazine-modiﬁed gold nanoparticles (Au NPs).27
Wang’s group developed a direct SERS technique for Hg2+
detection based on the investigation of the interaction between
silver nanoparticles (Ag NPs) and Hg2+.28 Our group has also
developed an SERS approach to detect As3+ by using
glutathione-functionalized Ag NPs and 4-MPY as the Raman
reporter.29 Au NPs and Ag NPs are both widely used in the
SERS-based assay but, generally speaking, Ag NPs is a much
more eﬃcient Raman substrate than Au NPs. It can provide 10-
fold to 100-fold higher SERS signals than the similar Au NPs,
which is mainly due to its d-s band gap, is in the ultraviolet
(UV) region, giving rise to less damping of the plasmon
mode.30,31
Accordingly, in the present study, we applied SERS
technique to the sensitive and selective detection of heparin
based on antiaggregation of 4-MPY functionalized Ag NPs
upon the presence of protamine. Protamine is a kind of natural
peptide with polypositive ion, which has ∼20 charges;32 its
special structure could lead to the aggregation of 4-MPY
functionalized Ag NPs, thus resulting in the changes in colors,
surface plasmon resonance absorption and Raman intensity of
4-MPY. Meanwhile, there is strong aﬃnity between protamine
and heparin, which has been used in clinical and experimental
observation.33 In the presence of heparin, the Raman
enhancement eﬀect of 4-MPY functionalized Ag NPs induced
by protamine would be decreased. The experiment results
proved that this sensing strategy provided a good performance
in terms of sensitivity, selectivity, linearity, and limits detection
of heparin in both standard aqueous solution and fetal bovine
serum sample.
■ EXPERIMENTAL SECTION
Reagents. Hydroxylamine hydrochloride (NH2OH·HCl) was
obtained from Tianjin Kermel Chemical Reagent Co. Ltd. (Tianjin,
China). Protamine sulfate salt, hyaluronic acid (HA) salt, and 4-
mercaptopyridine (4-MPY) were obtained from Sigma-Aldrich.
Heparin sodium salt (185 U/mg) from bovine intestinal mucosa,
chondroitin sulfate (Chs), silver nitrate (AgNO3), Rhodanine 6G
(R6G), and thymine (T) were purchased from Aladdin Chemistry Co.
Ltd. (Shanghai, China). Bovine serum albumin (BSA), glucose, and 4-
(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) were
purchased from Shanghai Shenggong Co. (Shanghai, China).
HEPES buﬀer solution used in the experiment was adjusted with 1
M sodium hydroxide (NaOH) to pH 7.4. Fetal bovine serum (FBS)
stock solution (HyClone, Thermo Scientiﬁc, Australia) and blood
samples (Collected from three adult Kunming male mice) were stored
at −20 °C and were thawed at room temperature before use. All other
chemicals were provided by Sinopharm Chemical Reagent (Shanghai,
China). Deionized water with 18.2 MΩ speciﬁc resistances obtained
from a Pall Cascada laboratory water system. All of the reagents were
of analytical grade and used without future puriﬁcation.
Apparatus. All measurements of SERS spectra were recorded
using Thermo Scientiﬁc RFS 100 Raman system equipped with a
microscope and a 632.8 nm diode-pumped He−Ne laser source.
Transmission electron microscopy (TEM) images were acquired on a
JEM-1230 electron microscope (JEOL Ltd., Japan) operating at 100
kV. UV−vis absorption spectra were performed on a Thermo
Scientiﬁc NanoDrop 2000C spectrophotometer (Gene Company
Ltd.). Zeta potential measurements were performed on Malvern
Zetasizer Nano-ZS90 (ZEN3590, Malvern Instruments Ltd., U.K.). All
glassware used in the experiment were washed with freshly prepared
aqua regia, rinsed thoroughly in deionized water and dried in air.
Preparation of Ag NPs. Ag NPs were prepared by reducing
AgNO3 using NH2OH·HCl at room temperature with slight
modiﬁcations.34 Brieﬂy, 10.44 mg of NH2OH·HCl was added to
89.0 mL of H2O and was mixed with 1 mL of 0.30 M NaOH to
maintain an alkaline pH. Then, 10 mL of 0.01 M AgNO3 was added to
the mixtures under stirring. The above solution was continuously
stirred for an additional 1 h. The prepared silver colloid was stored at
room temperature. TEM and UV−vis spectroscopy were used to
characterize the typical surface plasmon resonance peak and
morphology of the produced silver colloid. The size of prepared Ag
NPs was estimated to 35 ± 5 nm (size ranging from 30 to 55 nm is
widely used in SERS-based method), and zeta potential of Ag NPs was
measured as −38.9 mV.
Functionalization of Ag NPs with 4-MPY. 4-MPY of 250
μMwas prepared in double-distilled water. Then 50 μL of 4-MPY was
added to 4.95 mL of the prepared Ag NPs with stirring for 1 h, and the
mixture was subsequently left for overnight without disturbance at
room temperature. The zeta potential of 4-MPY functionalized Ag
NPs was measured as −38.1 mV. The zeta potential of Ag NPs was
measured as −38.9 mV, it was found that 4-MPY had little eﬀect on
the negatively charged Ag NPs.
SERS Detection of Heparin. The SERS detection of heparin was
performed at ambient temperature. Various concentrations of
protamine and heparin were prepared by 10 mM HEPES buﬀer
solution. The samples for heparin detection were prepared by adding
diﬀerent amounts of heparin (0−150 ng/mL) to the solution of 0.5
μg/mL of protamine for 2 min, then 80 μL of 4-MPY functionalized
Ag NPs were added to the above mixture and incubated for another 2
min. Finally, about 5 μL of the above mixture in the capillary tube was
detected by Raman spectrometry with an exposure time of 4 s.
Selective Detection of Heparin. In the experiments of selectivity
and practical assay, all samples were tested in a similar way. We
investigated the selectivity of the our approach for other potentially
competing substances (Na+, K+, Ca2+, Mg2+, Cl−, PO4
3‑, HPO4
2‑,
S2O4
2‑, glucose, BSA, ATP, HA, Chs) under the same optimized
conditions.
Analysis of Real Samples. FBS samples at 0.2 % (v/v) were
prepared by diluting the stock solutions with HEPES buﬀer (pH 7.4,
10 mM). Blood samples were added sodium citrate to prevent from
clotting, centrifuged, and then diluted to 30-fold with 10 mM HEPES
(pH 7.4). The real samples were spiked with standard protamine and
heparin at certain concentrations. Then the same procedure was
prepared as that of the standard solution detection mentioned above.
Safety Consideration. Aqua regia has strong oxidizing capacity
and adverse eﬀects on human health; thus, all of the experiments
involving aqua regia should be performed with gloves and protective
glasses. The waste solution of the experiment should be collectively
reclaimed to avoid polluting the environment.
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■ RESULT AND DISCUSSION
Sensing Mechanism of Heparin Sensor. A schematic
representation of the mechanism of SERS sensing heparin
based on antiaggregation of the 4-MPY functionalized Ag NPs
is illustrated in Scheme 1. During the process of SERS probe
synthesis, as a Raman reporter, 4-MPY, could replace parts of
the hydroxylamine ions, and contact with Ag NPs mainly
through Ag−S or Ag−N bond.35,36 As shown in Figures 1b and
2d, by adjusting the adding amount of Raman reporter 4-MPY,
the color of negatively charged Ag NPs colloid was still bright
yellow, which indicated that the 4-MPY functionalized Ag NPs
were well stabilized. Protamine, a low molecular weight protein,
has ∼20 positive charges in physiological condition and is rich
in basic arginine residues, and could be absorbed on the surface
of negatively charged 4-MPY functionalized Ag NPs through
electrostatic interaction. Thus protamine acted as a medium for
inducing the aggregation of negatively charged 4-MPY
functionalized Ag NPs as well as an obvious color change, as
seen from Figures 1c and 2g. And, as shown in Figure 2g, the
aggregated 4-MPY functionalized Ag NPs could produce great
SERS signals. However, in the simultaneous presence of
protamine and heparin in the sensing solution, the aggregation
of 4-MPY functionalized Ag NPs would be prevented because
of that protamine was hybridized with heparin ﬁrst, as seen
from Figures 1d and 2f. As we know, their strong electrostatic
binding has been used in experimental observation and clinical
application.32 Herein, we took advantage of their strong aﬃnity
to develop a SERS detection of heparin based on
antiaggregation of 4-MPY functionalized Ag NPs.
To demonstrate the feasibility of this sensor strategy, Raman
spectra, UV−vis absorption spectra, and TEM images were also
used to characterize the system. As shown in Figures 1 and 2, 4-
MPY functionalized Ag NPs were remained stable, and there
were strong SERS signals only in the simultaneous presence of
Ag NPs, 4-MPY, and protamine. On the contrary, there were
almost no SERS signals in the presence of heparin alone. And
with the adding of heparin, there was a signiﬁcant decrease in
the SERS intensity. In addition, the UV−vis spectra were added
to show the changes of typical surface Plasmon resonance peak
(see Figure S1 in the Supporting Information). And, only in the
presence of protamine alone could induce the aggregation of 4-
MPY functionalized Ag NPs. In the simultaneous presence of
protamine and heparin, 4-MPY functionalized Ag NPs were still
monodisperse.
Optimization of the Responsive Conditions. For the
best performance of our proposed sensing assay, several
responsive conditions were investigated including Raman
reporters and concentrations of protamine.
As seen from Figure S2 in the Supporting Information, three
kinds of Raman reporters were tested to optimize the suitable
reporter. As the Raman reporter, 4-MPY exhibited the strongest
SERS signals, which mainly due to their types of bindings with
Ag NPs. 4-MPY bonded with Ag NPs mainly through Ag−S or
Ag−N bond, and the stronger Ag−S bond played a major role
in the chemisorption process.37 The zeta potential of 4-MPY
functionalized Ag NPs was −38.1 mV, which was little aﬀected
by 4-MPY. R6G contacted with Ag NPs mainly through weak
electronic interaction, it could greatly aﬀect the surface negative
charges of Ag NPs and might have powerful competitive ability
with protamine, and then the zeta potential was reduce to
−27.0 mV. Thymine (T) contacted with Ag NPs through Ag−
N bond and the zeta potential was −38.3 mV. However, as seen
from Figure S2, T and R6G exhibited weak SERS signals while
4-MPY exhibited strong SERS signals in this method.
Considering all these reasons, we chose 4-MPY as Raman
reporter in the developed method.
As shown in Figure 2b, although Ag NPs could aggregate
after addition of protamine, there was no SERS signal.
Therefore, the Raman reporter played an important role in
this SERS based assay; the eﬀect of the concentration of 4-MPY
on the SERS intensity was investigated with ﬁve diﬀerent
concentrations ranging from 1.0 to 3.0 μM. The corresponding
Raman spectra are shown in Figure 3A; the largest signal was
achieved with 2.5 μM 4-MPY, and further increasing the
concentration of 4-MPY did not induce obviously enhancement
of SERS signal. Generally speaking, higher concentration of the
Raman reporter would induce Ag NPs aggregation, and thus,
the concentration of 2.5 μM was chosen in this work.
Eﬀect of the concentration of protamine added in the system
was further investigated to optimize the detection sensitivity
toward heparin, and the corresponding Raman spectra were
performed in Figure 3B. We noted that the concentration lower
than 0.5 μg/mL would be less eﬃcient and unfavorable to
lower detection limit, whereas protamine concentration higher
than 0.5 μg/mL did not induce obviously enhancement of
signal, which was mainly due to that protamine play a role of
stabilizer for 4-MPY functionalized Ag NPs at high
concentrations. Therefore, the concentration of 0.5 μg/mL
was employed for the sensing of heparin.
Sensitivity and Selectivity of the Sensor. Under the
above optimized conditions, the SERS spectra of the 4-MPY
functionalized Ag NPs in diﬀerent concentrations of heparin
were recorded. As shown in Figure 4A, there were many spectra
features that were attributed to 4-MPY bands which could be
used for indirect quantitative determination of heparin, such as
those at 712, 1015, 1066, 1099, 1227, and 1584 cm−1. The band
at 1015 cm−1 was related to ring-breathing vibrations.38 The
band at 1066 and 1227 cm−1 corresponded to the C−H
stretching mode, and 1584 cm−1 was assigned to C−C
stretching mode.39,40 The strongly enhanced band at 1099
cm−1 corresponding to the ring-breath/C−S stretching mode
indicated that 4-MPY was adsorbed onto the surfaces of the Ag
NPs through the sulfur atom.41,42 It was also supported by the
C−S stretching mode at 712 cm−1.39,42 We could clearly note
that the peak around 1099 cm−1 was the most prominent one,
Scheme 1. Schematic Diagram of the Proposed SERS
Method for Measuring Heparin Using 4-MPY
Functionalized Ag NPs
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and its intensity was very sensitive to the concentration of
heparin. Therefore, it was selected as an optimum peak for the
quantitative detection of heparin. This relationship is
expounded in Figure 4B; a satisfying linear relationship was
obtained over the range of 0.5−150 ng/mL with the correlation
coeﬃcient of 0.998. The minimum detectable concentration
was 0.5 ng/mL, which conﬁrmed the exquisite sensitivity of our
sensing assay.
To investigate the selectivity of our developed approach
toward heparin, the potential competing substances, including
10 mM of Na+, K+, Ca2+, Mg2+, Cl−, PO4
3‑, HPO4
2‑, S2O4
2‑,
glucose, 0.5 μg/mL of BSA, 100 ng/mL of ATP, 1000 ng/mL
of HA and Chs were examined under optimized conditions. As
shown in Figure 5, only the addition of 100 ng/mL of heparin
could obviously prevent the aggregation of Ag NPs through the
strong aﬃnity of protamine and heparin, resulting in a
signiﬁcation decrease of SERS signals. As shown in Figure S3
Figure 1. TEM images and color changes (bottom panel) corresponding to (a) Ag NPs; (b) 4-MPY-Ag NPs; (c) 4-MPY-Ag NPs + protamine (0.5
μg/mL); and (d) 4-MPY-Ag NPs + protamine (0.5 μg/mL) + heparin (150 ng/mL).
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in the Supporting Information, we have also investigated
diﬀerent concentrations of HA and Chs, analogues of heparin,
at the same concentration, as well as 10-fold concentration of
heparin, the selectivity of this method was still ideal. It is mainly
due to their low charge density per repeat unit. Generally
speaking, heparin possesses one carboxylate per repeat unit and
three sulfate groups; however, HA has only one carboxyl group,
and Chs has one sulfate and one carboxylate group. Thus, the
electrostatic attraction between protamine and HA or Chs was
obviously weaker than that between protamine and heparin.18
All these results indicated that the developed sensor program
possessed excellent selectivity and reliability toward heparin.
Sensing Performances in Real Samples. To test the
practicality of the developed sensing strategy for practical
sample analysis, heparin was measured in FBS and blood
samples. Here, heparin was complicated biological ﬂuids,
suﬀering from matrix eﬀect. As seen from Figure 6, 0.8 μg/
mL protamine was selected for eliminating the possible matrix
interference of FBS samples. The peak around 1099 cm−1
remained as an optimum peak for the quantitative detection of
heparin in FBS samples. SERS intensity response versus
heparin concentrations (0−400 ng/mL) was shown in Figure
Figure 2. Raman spectra of (a) Ag NPs; (b) Ag NPs + protamine (0.5
μg/mL); (c) Ag NPs + heparin (150 ng/mL); (d) 4-MPY-Ag NPs;
(e) 4-MPY-Ag NPs + heparin (150 ng/mL); (f) 4-MPY-Ag NPs +
protamine (0.5 μg/mL) + heparin (150 ng/mL); (g) 4-MPY-Ag NPs
+ protamine (0.5 μg/mL).
Figure 3. (A) Eﬀect of the concentration of 4-MPY (from 1.0 to 3.0
μM) of the sensing system on the Raman signal intensity in the
presence of 0.5 μg/mL protamine. (B) Eﬀect of the concentration of
protamine (from 0.1 to 0.6 μg/mL) of the sensing system on the
Raman signal intensity in the presence of 2.5 μM 4-MPY. The error
bars represent the standard deviations based on three independent
measurements.
Figure 4. (A) SERS spectra changes of proposed probe upon addition
of diﬀerent concentrations of heparin (0−150 ng/mL). (B) Plot of
corresponding intensity of the Raman band at 1099 cm−1 versus the
concentration of heparin range from 0.5 to 150 ng/mL (R2 = 0.998).
Figure 5. Raman corresponding intensity responses of proposed probe
in 10 mM HEPES solutions (pH 7.4) upon the addition of heparin
and various potentially coexisting species respectively: 10 mM Na+, K+,
Ca2+, Mg2+, Cl−, PO4
3‑, HPO4
2‑, S2O4
2‑, glucose; 0.5 μg/mL BSA; 1000
ng/mL HA and Chs; 100 ng/mL ATP and heparin.
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7A, and a satisfying linear relationship was obtained over the
range of 1−400 ng/mL with the correlation coeﬃcient of 0.987,
as seen from Figure 7B. SERS spectra change between 10 and
50 ng/mL was small. However, we could distinguish easily
through the magniﬁed image, as seen from Figure S4 in the
Supporting Information. We noted that the minimum
detectable concentration value was similar to that in the
standard solution of HEPES. As shown in Figure S5 in the
Supporting Information, the matrix interference of blood
samples was not able to eliminate very well even at 80 μg/
mL of protamine spiked. As far as we know, blood is very
complicated biological ﬂuids. Compared with serum, blood
contains abundant ﬁbrinogen and other enzymes, and the
complicated matrix might disturb electrostatic interaction of the
detection system; thus, we think this probe is more suitable for
determination heparin of in FBS samples.
■ CONCLUSIONS
A novel SERS sensing strategy has been developed for the
detection of heparin in aqueous media based on antiaggregation
of 4-MPY functionalized Ag NPs. By taking advantage of the
strong aﬃnity between protamine and heparin, excellent
analytical performance in terms of sensitivity, selectivity,
linearity, and limits detection of heparin was attained.
Compared with other methods for the detection of heparin,
it provided good performance as well (as seen from Table S1 in
the Supporting Information), and materials used in our method
were inexpensive and available commercially. Furthermore, this
sensing method exhibits satisfying results in FBS samples,
which indicates a great practicality for application in real
analysis/monitoring and other related ﬁelds.
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